MediSieve's CEO explains magnetic blood filtration at Xcelerate Startup Pitch Competition

George Frodsham, CEO at MediSieve, won first runner up for Best Business Plan at the Xcelerate Startup Pitch Competition hosted by EBD Group and Xcelerate Insight during Biotech Week Boston in September, 2018. With the ability to specifically and selectively remove disease-causing agents from the blood, MediSieve’s magnetic blood filtration has the potential to transform the treatment of blood borne diseases such as sepsis, leukemia and malaria. The pitch competition is designed to give early stage companies exposure to possible investors and partners, and is judged by top venture capitalists and industry experts.